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Abstract 
The formation of a twist-brendane via intramolecular enolate alkylation is described. Conversion 
of bicyclo[2.2.1]heptane scaffold present in this twist-brendane through a Grob-type 
fragmentation to unravel a functionalized bicyclo[2.2.2] system which contains all the necessary 
carbon atoms of the lipophilic core structure of nor-platencin, a platencin analogue is presented. 
Synthesis of core structure of platencin was also accomplished by extending this strategy to a 
starting material possessing a surrogate for the exocyclic methylene group. 
 
Keywords: Enones, Grob-type fragmentation, intramolecular enolate alkylation, twist-brendane, 
platencin 
 
 
 
Introduction 
 
Intramolecular enolate alkylation has been a key step for stereoselective construction of 
cycloalkanes in the total synthesis of natural products of modest complexity,1-4 and in the 
synthesis of strain free tricyclononane like twist-brendane.5-8 The synthesis of natural products 
involving the Grob fragmentation reaction, a reliable synthetic tool for the cleavage of C‒C 
sigma bond leading to useful building blocks, as a key step has been gaining much attention in 
recent past due to its high efficiency and stereoselectivity.9-13 
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Figure 1. Molecular Structure of Platencin (1), Core Structure (2) of Platencin. Twist-brendane 
Derivative (5). 
 
 As a novel potent antibiotic, platencin14,15 inhibits two proteins essential for bacterial fatty 
acid biosynthesis, β-ketoacyl carrier protein synthase II (FabF) and III (FabH) with similar 
potency. Owing to their interesting novel chemical scaffold and biological activity as 
antibacterial agents platencin and its congeners16 have attracted widespread attention amongst 
synthetic chemists since their discovery with prospect that these would be used as lead 
compounds for the development of a valuable class of antibiotics. Although platencin shows the 
potent antibacterial activity it suffers from the poor in vivo efficacy that is attributed to its rapid 
clearance from tissues.16,17 So the synthesis of new potent analogues of platencin with improved 
potency and pharmacokinetic properties suitable for clinical trials is in high demand.17 
 Platencin core structure constitutes tricyclic system with a bicyclic octane ring having exo-
methylene group, fused with a cyclohexenone ring. Many synthetic strategies have been 
developed for the construction of platencin core structure involving key steps like homoallyl 
radical rearrangement of bicyclo[3.2.1]octane to bicyclo[2.2.2]octane,18-22 intramolecular Diels-
Alder reaction,22-24 intramolecular Michael addition,25 Michael addition followed by aldol 
condensation,26 ring closing metathesis reaction,27,28 pinacol coupling reaction,29 radical 
cyclization reactions30-33 and intramolecular aldol reaction.34 
 Although nor-platencin is less potent than its parent molecule, but serves as a convenient 
target as it lacks the acid-sensitive exo-methylene group present in platencin which is also 
responsible for the decrease in the metabolic stability of platencin.35 In this paper we report 
synthesis of platencin core structures which features the construction of tricyclic core via a twist-
brendane derivative, followed by Grob-type fragmentation and Robinson annulation.  
 
 
Results and Discussion 
 
During the course of our studies on base mediated bridgehead elimination and substitution 
reactions,36 we observed the formation of a twist-brendane derivative 5 through intramolecular 
enolate alkylation in 70% yield along with the originally intended product 6 (yield 17%) from 4 
(Scheme 1). 
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Scheme 1. Synthesis of Twist-brendane Derivative 5. 
 
 Synthesis of the parent twist-brendane5 has been described in the literature by intramolecular 
enolate alkylation using NaH in DMF at 60 °C followed by deoxygenation. We have also 
adopted the same protocol, but with slight modification wherein THF was used instead of DMF, 
to avoid the side product 6 and observed smooth formation of twist-brendane 5 without any side 
products. The complete sequence involved Michael addition of acetone to the enone 3 to give 
intermediate 4 which on exposure to NaH in THF at 60 °C provided the twist-brendane 5 in 89% 
yield (Scheme 1). The structure of twist-brendane was unequivocally proved by single crystal X-
ray analysis (Scheme 1). Compared to the parent twist-brendane, compound 5 is equipped with 
maneuverable functional groups such as a ketal moiety at C-7 and a suitably positioned keto 
group for the execution of Grob-type fragmentation12,13 to unravel a useful bicyclo[2.2.2]octane 
derivative. 
 As anticipated, the Grob-type fragmentation of 5 with pTSA in toluene afforded a separable 
mixture of bicyclo[2.2.2]octane derivative 7 (Scheme 2). A closely related compound to 7, 
having exo-methylene group sans the chloro and ester substitutions has been reported for the 
synthesis of platencin core.33 Our attempts to cyclize 7 via Robinson annulation using 
NaOH/EtOH (or MeOH) even at reflux conditions failed, yielding complex mixtures. The 
presence of chlorine substituents might be responsible for the observed complications. In this 
context, we initially carried out the hydrodehalogenation reaction of the mixture 7 using 
nBuSnH/AIBN which yielded a complex mixture. However, treatment of 7 with zinc dust in 
acetic acid at room temperature furnished the diketone 8 as a single diastereomer (Scheme 2).  
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Scheme 2. Synthesis of nor-platencin skeleton. 
 
 Having the diketo ester 8 in hand, our next task was to convert it to tricyclic enone 9. This 
was achieved by refluxing 8 in NaOH/MeOH for 12 h followed by diazomethane workup which 
provided a separable mixture of diastereomers 9a/9b in 1:1 exo/endo ratio of methyl ester 
(Scheme 2). Reduction enone 9a was carried out using Raney nickel33,37 in THF to obtain the 
keto ester 10 as a single diastereomer in 83% yield. Several two-step protocols are available in 
the literature for the conversion of ketone to enone moiety. Silylation followed by 2-
iodoxybenzoic acid (IBX)38 oxidation is a well practiced method in the synthesis of 
platencin.22,23,30 However, in our case Nicolaou’s39 one-step protocol furnished the desired 
compound 11 when ketoester 10 was treated with IBX in toluene/DMSO at 65 °C along with a 
minor product 9a (Scheme 2). Structure of 11 was confirmed by single crystal structure X-ray 
analysis (Scheme 2). 
 Next, we planned for the synthesis of the core structure of platencin incorporating a keto 
functionality and adopted similar reaction sequences of the synthesis of core structure of nor-
platencin. Synthesis commenced with bromination (Scheme 3).  Our initial attempts for 
bromination at the α-methyl group of ketone 18 with NBS in THF,40 NBS/TMSOTf in CH3CN,
41 
NBS/DBU in CH3CN,
42 and NBS/AIBN in CCl4
43 were sluggish. Nevertheless, conventional 
brominating agent, Br2 in MeOH
44 (at 0 °C → rt), provided the bromination product in good 
yield. Protection of ketone using pTSA in refluxing toluene delivered compound 19 in 79% 
yield. On exposure to Ru-LDH/NaIO4-NaHCO3
45-47 the intermediate 19 provided diketone 17 in 
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excellent yield. Subjecting this to Wittig reaction gave enone 16 in 97% yield. Michael addition 
of enone 16 with acetone using NaOH (aq) gave intermediate 20 in near quantitative yield 
(Scheme 3). NaH mediated intramolecular enolate alkylation proceeded as expected to provide 
twist-brendane 15. 
 The conversion of twist-brendane to bicyclo[2.2.2]octane 21 was easily achieved through a 
smooth Grob-type fragmentation by treatment of 15 with pTSA in toluene at 80 °C (Scheme 3). 
Hydrodechlorination with zinc dust in AcOH gave diketone 14. Robinson annulation of 14 using 
NaOH in MeOH at reflux temperature afforded tricyclic enone 22 in 4:1 exo/endo ratio, as 
determined from 1H NMR. Deprotection of ketal group with 6N HCl at room temperature gave 
13 in good yield. Regioselective Wittig reaction of unconjugated ketone group in 13 to exo-
methylene proceeded smoothly at -78 °C to give dienone 12 in 72% yield (Scheme 3). As Wittig 
reaction was carried out under strong basic condition one can expect the abstraction of proton 
adjacent to the ester group. Once the carbanion is formed the bulky ester group would prefer 
relatively free room exo position and hence the conversion of endo isomer to exo occurs, which 
can be accounted for the high diastereoselectivity (exo:endo 10:1) in the Wittig reaction. 
 
 
 
Scheme 3: Synthesis of platencin core.  
 
 The stereochemistry of the major component in 13 was arrived at from 2D NMR data 
analysis of the mixture. Based on the correlations of proton signals at δ 2.44 (m, 1H) and 2.36 
(m, 1H) (CH2 group adjacent to CO in the bicyclooctane ring) with carbon at δ 210.9 in HMBC, 
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these were assigned to methylene group attached to ketone. Similarly, methine group attached to 
methyl ester was deduced by correlation between proton at δ 2.87-2.79 (m, 1H) and carbon at δ 
174.3, which also shows correlation with methoxy group at δ 3.72. The absence of correlation 
between the protons at δ 2.52-2.34 and δ 2.87-2.79 in NOESY confirms that the methine proton 
is endo and the ester group is exo in compound 13 and also 12. As expected, during the strongly 
basic Witting reaction conditions, further isomerization of 13 resulted in substantial enhancement 
in exo/endo ratio from 4:1 in 13 to 10:1 in 12. 
 
 
Conclusions 
 
In conclusion, we have synthesized functionalized twist-brendane derivatives through 
intramolecular enolate alkylation. We have demonstrated a strategy for the conversion of 
bicyclo[2.2.1]heptane to bicyclo[2.2.2]octane derivative through the formation twist-brendane 
followed by Grob-type fragmentation. The fragmented products were carried forward for the 
synthesis of the core structures of both nor-platencin and platencin. Structures and 
stereochemistry of some of the intermediates were confirmed by single crystal X-ray analysis 
and 2D NMR analysis. 
 
 
Experimental Section 
 
General. Unless otherwise specified, all reactions were carried out in oven dried glassware, 
under argon atmosphere. Melting points were determined on an electrothermal melting point 
apparatus and are uncorrected. THF was dried by refluxing over sodium metal. Sodium 
methoxide was prepared from sodium and methanol. Zinc was activated by 10% HCl before use. 
DMSO was distilled from anhydrous CaSO4/calcium hydride. Potassium tert-butoxide was 
sublimed before use. 1H and proton decoupled 13C NMR spectra were recorded in 400 and 100 
MHz, respectively. The NMR samples were prepared by dissolving in CDCl3, chemical shifts (δ 
ppm) are reported with reference to either internal standard tetramethylsilane, TMS (δH= 0.00 
ppm) or CHCl3 (δH = 7.27 ppm) for 
1H NMR and CHCl3 [δC=77.00 ppm (central line of the 
triplet)] chemical shifts (δ ppm) for 13C NMR. The multiplicity are reported as follows s = 
singlet, d = doublet, dd = double doublet, t = triplet, dt = double triplet, td = triple doublet, q = 
quartet, br = broad m = multiplet and the coupling constants were in Hz. HRMS was performed 
using a Q-TOF multimode source. 
 
(1R*,4R*,6R*)-6-(2-Bromoethyl)-1,4-dichloro-7,7-dimethoxy-3-(3-oxobutyl)bicyclo[2.2.1] 
heptan-2-one 4. To a stirred solution of enone 336 (5 g, 13.96 mmol) in acetone (140 mL) was 
added aqueous sodium hydroxide solution (8.3 mL, 16.7 mmol, 2M) at 0 oC for 5 min. After 
being stirred for 1 h, 5 ml of 10% HCl was added, solvent was evaporated under reduced 
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pressure and diluted with EtOAc (150 mL), organic phase was separated aqueous phase was 
extracted with EtOAc (200 ml x 2) combined organic phases were washed with water (200 mL), 
brine (100 mL), dried over Na2SO4 and concentrated in vacuo. The resulting crude was purified 
over silica gel column chromatography (eluent: EtOAc-Hexane = 1: 5) to afford Michael product 
4 (5.67 g, 98%) as a colorless liquid. 1H NMR (400 MHz, CDCl3) δ 3.69 (s, 3H), 3.66 (s, 3H, 
minor isomer), 3.60 (s, 3H), 3.58 (s, 3H, minor isomer), 3.47-3.40 (m, 1H), 3.38-3.30 (m, 1H), 
2.99 (ddd, J 5.9, 8.8, 18.6 Hz, 1H), 2.86 (ddd, J 2.7, 5.0, 7.5 Hz, 1H), 2.79-2.73 (m, 1H), 2.73-
2.63 (m, 2H), 2.61-2.52 (m, 1H), 2.19 (s, 3H), 2.17 (s, 3H, minor isomer), 2.08-1.75 (m, 5H), 
1.51-1.39 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 207.3, 202.4, 104.7, 80.4, 69.3, 55.7, 51.8, 
51.7, 41.4, 40.4, 36.1, 32.6, 30.4, 30.0, 18.2. HRMS (ESI): m/z calcd for C15H25BrCl2NO4 [M + 
NH4]
+ 432.0344; found: 432.0298. 
Twist-brendane Derivative 5. To a stirred solution of 4 (5 g, 12.01 mmol) in THF (150 mL) 
was added sodium hydride (625 mg, 15.61 mmol, 60% in mineral oil) in two portions at 0 oC and 
allowed to warm to rt and then heated at 60 oC. After completion of starting material (monitored 
by tlc) 50 mL of water was added at 0 oC, solvent was evaporated under reduced pressure diluted 
with EtOAc (200 ml), organic phase was separated aqueous phase was extracted with 
EtOAc(150 ml x 2), combined organic phases were washed with water (200 mL), brine (100 
mL), dried over Na2SO4 and concentrated in vacuo. The resulting crude was purified over silica 
gel column chromatography (eluent: EtOAc-Hexane = 1:5) to afford twist-brendane 5 (3.58 g, 
89%) as a colorless crystalline solid (solvent: acetonitrile). mp: 142-144 oC.1H NMR (400 MHz, 
CDCl3) δ 3.61 (s, 3H), 3.42 (s, 3H), 2.78-2.57 (m, 3H), 2.49 (td, J 2.2, 4.4 Hz, 1H), 2.17-2.06 
(m, 2H), 2.13 (s, 3H), 2.02-1.91 (m, 1H), 1.85 (d, J 11.2 Hz, 1H), 1.73-1.62 (m, 3H). 13C NMR 
(100 MHz, CDCl3) δ 208.3, 204.5, 104.5, 78.1, 73.3, 56.6, 51.6, 51.1, 47.9, 39.1, 36.73, 31.2, 
29.9, 24.6, 24.3. HRMS (ESI): m/z calcd for C15H24Cl2NO4 [M + NH4]
+352.1082; found: 
352.1076. 
(1R,*3R*,4R*,6R*)-6-(2-Bromoethyl)-1-chloro-4,7,7-trimethoxy-3-(3-oxobutyl)bicyclo- 
[2.2.1]heptan-2-one6. To a stirred solution of 4 (210 mg, 0.50 mmol) in methanol (2.5 mL) was 
added sodium methoxide (81 mg, 1.5 mmol) at room temperature and slowly allowed to warm to 
reflux temperature. After being refluxed for 4 h, reaction mixture cooled to 0 °C, 1 mL of water 
was added diluted with EtOAc (40 mL), organic phase was separated, aqueous phase was 
extracted with EtOAc (30 mL x 3) combined organic phases were washed with water (40 mL), 
brine (20 mL), dried over Na2SO4 and evaporated under reduced pressure. The resulting residue 
was purified over silica gel column chromatography (10-20% EtOAc in hexane) to give 
compounds 5 (117 mg, 70% colorless crystalline solid (needles), crystallized from acetonitrile) 
and 6 (35 mg, 17%, colorless liquid). Data for compound 6: 1H NMR (400 MHz, CDCl3) δ 3.65-
3.59 (m, 1H), 3.62 (s, 3H), 3.59-3.50 (m, 1H), 3.55 (s, 3H), 3.51 (s, 3H), 2.93-2.84 (m, 1H), 
2.79-2.64 (m, 3H), 2.64-2.54 (m, 1H), 2.16 (s,  3H), 2.01-1.91 (m, 1H), 1.79 (q, J 7.7 Hz, 2H), 
1.52 (dd, J 3.9, 12.2 Hz, 1H), 1.40-1.32 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 207.8, 203.7, 
106.1, 83.5, 80.3, 53.4, 52.6, 51.01, 51.00, 42.7, 41.5, 38.1, 32.6, 30.1, 27.6, 18.3. IR (neat) 
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2927, 1762, 1713, 1451, 1264, 1212, 1164, 1096, 1033, 986 cm-1; HRMS (ESI): m/z calcd for  
C16H25BrClO5 [M + H]
+ 411.0574; found: 411.0573. 
(1R*,2R*,4S*)-Methyl 2,5-dichloro-6-oxo-1-(3-oxobutyl)bicyclo[2.2.2]octane-2-carboxylate 
7: To a stirred solution of 5 (500 mg, 1.49 mmol) in toluene (15 mL) was added pTSA (368 mg, 
1.93 mmol) at rt and then slowly heated at 80 oC. After being heated for 5 h solvent was 
evaporated under reduced pressure, the residue was partition between EtOAc (80 mL) and water 
(25 mL), organic phase was separated aqueous phase was extracted with EtOAc (75 mL x 2) 
combined organic phases were washed with aq. NaHCO3 solution (30 mL), water (80 mL x 2), 
brine (40 mL), dried over Na2SO4 and evaporated to dryness. The resulting crude was purified 
over silica gel column chromatography (eluent: EtOAc-Hexane = 1:4) to afford fragmented 
products 7 (418 mg, 88%) in 1:1 mixture of separable diastereomers as pale yellow solids 
(needles- crystallized from acetonitrile). Data for less polar compound (7a); mp: 76-78 °C (A); 
Rf = 0.6 (15% EtOAc in hexane). 
1H NMR (400MHz, CDCl3) δ 4.31 (d, J 1.5 Hz, 1H), 3.78 (s, 
3H), 2.69-2.61 (m, 1H), 2.61-2.50 (m, 2H), 2.45 (d, J 2.9 Hz, 1H), 2.39-2.27 (m, 1H), 2.27-2.14 
(m, 2H), 2.12 (s, 3H), 1.92-1.78 (m, 2H), 1.77-1.59 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
207.5, 204.3, 171.5, 72.4, 59.2, 54.0, 53.4, 44.2, 38.1, 34.3, 29.9, 23.3, 23.2, 17.9. HRMS (ESI): 
m/z calcd for C14H22Cl2NO4 [M + NH4]
+ 338.0926; found: 338.0908. Data for polar compound 
(7b): mp: 80-82 °C; Rf = 0.6 (15% EtOAc in hexane); 
1H NMR (400 MHz, CDCl3) δ 4.25 (t, J 
2.0 Hz, 1H), 3.81-3.74 (m, 3H), 3.04 (td, J 2.1, 15.3 Hz, 1H), 2.56-2.47 (m, 1H), 2.46-2.40 (m, 
1H), 2.33 (dd, J 2.4, 3.9 Hz, 1H), 2.31-2.27 (m, 1H), 2.20-2.13 (m, 2H), 2.12 (s, 3H), 1.99-1.87 
(m, 1H), 1.81 (ddd, J 3.7, 6.1, 9.8 Hz, 2H), 1.63-1.54 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 
207.4, 203.9, 170.2, 74.1, 59.1, 53.7, 52.9, 38.5, 38.0, 35.1, 29.8, 22.8, 22.2, 22.0. HRMS (ESI): 
m/z calcd for  C14H19Cl2O4 [M + H]
+ 321.0660; found: 321.0662. 
(1S*,2S*,4S*)-Methyl 6-oxo-1-(3-oxobutyl)bicyclo[2.2.2]octane-2-carboxylate 8. To a stirred 
solution of 7 (290 mg, 0.9 mmol) in AcOH (5 mL) was added zinc dust (236 mg, 3.61 mmol) at 
room temperature. After being stirred for 6 h (reaction monitored by TLC), reaction mixture was 
diluted with EtOAc (50 mL) and filtered through cotton washed with EtOAc (80 mL). The 
filtrate was washed with saturated NaHCO3 solution (25 mL), water (30 mL x 2), brine (20 mL), 
dried over Na2SO4 and concentrated under reduced pressure. Silica gel column (eluent:Ethyl 
acetate- hexane = 1: 3) purification of the resulting crude afforded diketo ester 8 (185 g, 82%) as 
pale yellow liquid; Rf = 0.5 (30% EtOAc in hexane). 
1H NMR (400 MHz, CDCl3) δ3.69-3.59 (m, 
3H), 2.81 (dd, J 5.4, 11.2 Hz, 1H), 2.58-2.47 (m, 1H), 2.47-2.34 (m, 2H), 2.31 (t, J 2.7 Hz, 1H), 
2.28-2.19 (m, 1H), 2.14 (s, 3H), 2.07 (tdd, J 2.8, 11.1, 13.8 Hz, 1H), 1.88-1.77 (m, 2H), 1.76-
1.61 (m, 3H), 1.61-1.49 (m, 2H); ). 13C NMR (100 MHz, CDCl3) δ 213.4, 208.4, 175.1, 52.0, 
46.4, 46.3, 44.3, 38.2, 30.2, 29.8, 27.1, 26.8, 25.6, 24.6; IR (neat) 2945, 2873, 1719 (br.), 1440, 
1360, 1165, 1094 cm-1; HRMS (ESI): m/z calcd for C14H24NO4 [M + H]
+ 270.1705; found: 
270.1688. 
Enone 9. To a stirred solution of 8 (180 mg, 0.71 mmol) in MeOH (32 mL) was added sodium 
hydroxide (200 mg, 5 mmol) at room temperature and then slowly heated at reflux temperature. 
After being refluxed for 15 h (monitored by TLC), 3 mL of 10% HCl was added at 0 oC, solvent 
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was evaporated under reduced pressure, the residue was partition between EtOAc (50 mL) and 
water (10 mL), organic phase was separated and the aqueous phase was extracted with EtOAc 
(50 mL x 3) combined organic phases were washed with water (30 mL x 2), brine (20 mL), dried 
over Na2SO4 and evaporated dryness. The resulting crude was dissolved in MeOH (3 mL) cooled 
to 0 oC, and then a solution of CH2N2 in ether was added until yellow color persist. A pinch 
AcOH was added to quench excess of diazomethane. Reaction mixture was concentrated under 
reduced pressure and the resulting crude was purified over silica gel column chromatography 
(eluent:Ethyl acetate- hexane= 1: 4) to give enone 9 (122 mg, 73%) in 1:1 mixture of separable 
diastereomers as pale yellow liquids. Data for compound 9a; Rf = 0.65 (30% EtOAc in hexane). 
1H NMR (400 MHz, CDCl3) δ 5.88 (t, J 1.7 Hz, 1H), 3.71 (s, 3H), 2.78-2.68 (m, 1H), 2.51-2.44 
(m, 2H), 2.45-2.36 (m, 2H), 2.09-1.95 (m, 2H), 1.95-1.89 (m, 1H), 1.89-1.79 (m, 2H), 1.72-1.61 
(m, 3H), 1.64-1.54 (m, 1H).13C NMR (100 MHz, CDCl3) δ 198.2, 174.6, 169.2, 124.5, 51.7, 
43.5, 36.3, 35.6, 33.73, 30.2, 29.6, 25.8, 25.4, 25.2. IR (neat) 2928, 2856, 1723, 1682, 1481, 
1392, 1359, 1279, 1194, 1165, 1063 cm-1; HRMS (ESI): m/z calcd for  C14H19O3 [M + H]
+ 
235.1334; found: 235.1331. Data for compound 9b:Rf = 0.6 (30% EtOAc in hexane). 
1H NMR 
(400 MHz, CDCl3) δ5.94 (s, 1H), 3.66 (s, 3H), 2.73 (dd, J 2.2, 18.3 Hz, 1H), 2.67 (dd, J 4.9, 10.8 
Hz, 1H), 2.45 (d, J 15.7 Hz, 1H), 2.41-2.34 (m, 1H), 2.26-2.16 (m, 1H), 2.06-1.92 (m, 3H), 1.91-
1.81 (m, 2H), 1.74-1.49 (m, 4H).13C NMR (100 MHz, CDCl3) δ197.9, 175.4, 168.1, 125.6, 51.8, 
47.6, 36.6, 36.0, 33.8, 31.9, 30.4, 30.3, 25.3, 25.2; IR (neat) 2924, 2864, 1729, 1680, 1480, 1392, 
1194, 1165, 1063 cm-1; HRMS (ESI): m/z calcd for C14H18O3Na [M +Na]
+ 257.1154; found: 
257.1151 
Keto ester 10. To a stirred solution of 9a (30 mg, 0.128 mmol) in THF (2 mL) was added Ra-Ni 
(3 x 0.3 g) three times after every 1 h at room temperature. After being stirred for 10 h, reaction 
mixture was diluted with EtOAc (20 mL) filtered through silica pad washed with EtOAc (30 
mL). The filtrate was concentrated under reduced pressure. The resulting residue was purified 
over silica gel column chromatography (eluent: Ethyl acetate-hexane = 1:4) afforded keto ester 
10 (25 mg, 83%) as a colorless liquid. Rf = 0.5 (15% EtOAc in hexane). 
1H NMR (400 MHz, 
CDCl3) δ3.70 (s, 3H), 2.77 (t, J 14.2 Hz, 1H), 2.57 (dd, J 6.6, 10.5 Hz, 1H), 2.29-1.99 (m, 4H), 
1.99-1.75 (m, 3H), 1.75-1.62 (m, 2H), 1.61-1.47 (m, 4H), 1.45-1.43 (m, 1H), 1.34-1.27 (m, 
1H).13C NMR (100 MHz, CDCl3) δ 212.6, 178.2, 52.0, 46.1, 45.4, 38.8, 38.4, 37.9, 35.1, 33.9, 
33.6, 31.1, 25.1, 24.3. IR (neat) 2926, 2862, 1725, 1713, 1453, 1434, 1359, 1262, 1193, 1169, 
1030, 990 cm-1. HRMS (ESI): m/z calcd for C14H20O3H [M + H]
+ 237.1491; found: 237.1485. 
Enone 11. To a stirred solution of 10 (10 mg, 0.042 mmol) in toluene (0.8 m) and DMSO (0.4 
mL) was added IBX (28 mg, 0.096 mmol) at room temperature and slowly heated at 70 °C. After 
being stirred for 2 days, reaction mixture was diluted with EtOAc (20mL), washed with 5% 
NaHCO3 aqueous solution, organic phase was separated, aqueous phase was extracted with 
EtOAc (15 mL x 3) combined organic phase was washed with water (15 mL), brine (10mL) 
dried over Na2SO4 and concentrated in vacuo. The resulting crude was purified over silica gel 
column chromatography (20% EtOAc in hexane) to afford compound 11 (6.4 mg, 70% yield) as 
colorless solid (crystalline- crystallized from EtOAc: hexane (1:2)), mp: 44-46 °C; Rf = 0.6 (20% 
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EtOAc in hexane). 1H NMR (400 MHz, CDCl3) δ 6.62 (d, J 9.8 Hz, 1H), 5.93 (d, J 9.8 Hz, 1H), 
3.58 (s, 3H), 2.66 (dd, J 3.9, 11.2 Hz, 1H), 2.43-2.13 (m, 4H), 2.01-1.84 (m, 2H), 1.81-1.54 (m, 
4H), 1.54-1.40 (m, 2H).13C NMR (100 MHz, CDCl3) δ 200.4, 176.0, 155.3, 128.1, 51.6, 45.1, 
41.1, 36.7, 35.6, 35.1, 21.4, 28.4, 24.4, 24.1. IR (neat) 2933, 2866, 1727, 1680, 1452, 1435, 
1357, 1257, 1200, 1174, 1074, 923 cm-1. HRMS (ESI): m/z calcd for C14H19O3 [M + H]
+ 
235.1334; found: 235.1332 
2-Bromo-1-((1S*,2R*,4S*)-1,4,5,6-tetrachloro-7,7-dimethoxybicyclo[2.2.1]hept-5-en-2-
yl)ethanone I. To a stirred solution of Diels-Alder adduct 17 (5g, 14.97 mmol) in MeOH (20 
mL) was added bromine (2.6 g, 16.46 mmol) at 0 oC and allowed to warm to room temperature. 
After being stirred for 8 h (monitored by tlc) 15 mL of water was added at 0 °C and stirred for 1 
h. The reaction mixture was diluted with EtOAc (150 mL), organic phase was separated, aqueous 
phase was extracted with EtOAc (100 mL x 3) combined organic phase was washed with 10% 
Na2CO3 solution (30 mL), water (100 mL x 2), brine (60 mL), dried over Na2SO4 and 
concentrated under reduced pressure. The resulting crude was purified over silica gel column 
chromatography (3% EtOAc in hexane) to afford intermediate I (5.13 g, 83%) as a colorless 
liquid, Rf = 0.4 (5% EtOAc in hexane). 
1H NMR (400 MHz, CDCl3) δ 4.20 (d, J 13.1 Hz, 1H), 
4.09 (d, J 13.2 Hz, 1H), 3.99 (dd, J 5.4, 7.8 Hz, 1H), 3.65 (s, 3H), 3.57 (s, 3H), 2.41-2.37 (m, 
2H), 1.61 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 197.6, 131.2, 126.4, 112.1, 74.1, 53.9, 52.9, 
51.9, 37.8, 35.2. IR (neat): 2986; 2951, 2844, 1728, 1603, 1440, 1390, 1335, 1278, 1252, 1188, 
1121, 1096, 985 cm-1. HRMS (ESI): m/z calcd for C11H15BrCl4NO3 [M + NH4]
+ 429.8960; 
found: 429.8934. 
2-(Bromomethyl)-2-((1S*,2R*,4S*)-1,4,5,6-tetrachloro-7,7-dimethoxybicyclo[2.2.1]hept-5-
en-2-yl)-1,3-dioxolane 19. To a stirred solution of above obtained intermediate I (4 g, 9.68 
mmol) in toluene (30 mL) were added pTSA (368.4 mg, 1.93 mmol) and ethylene glycol (1.5 g, 
24.2 mmol) at room temperature and then refluxed with Dean-Stark apparatus. After being 
refluxed for 48 h, solvent was evaporated and the residue was partitioned between EtOAc (150 
mL) and water (40 mL), organic phase was separated and aqueous phase was extracted with 
EtOAc (100 mL x 3) combined organic phase was washed with NaHCO3 solution (45 mL), water 
(150 mL), brine (100 mL), dried over Na2SO4 and concentrated under reduced pressure. The 
resulting crude was purified over silica gel column chromatography (5% EtOAc in hexane) to 
give 19 (3.5 g, 79%) as colorless liquid; Rf = 0.55 (4% EtOAc in hexane). 
1H NMR (400 MHz, 
CDCl3) δ4.16-4.08 (m, 1H), 4.07-3.97 (m, 3H), 3.60 (s, 3H), 3.54 (s, 3H), 3.50 (d, J 11.3 Hz, 1H 
), 3.44 (dd, J 4.9, 9.5 Hz, 1H), 3.42 (d, J 11.3 Hz, 1H ), 2.47 (dd, J 9.8, 11.7 Hz, 1H), 1.80 (dd, J 
4.9, 11.7 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 129.2, 128.1, 112.3, 108.6, 76.3, 73.6, 66.7, 
65.1, 52.7, 51.6, 49.2, 38.5, 35.1. IR (neat): 2983; 2951, 2898, 1732, 1605, 1448, 1393, 1335, 
1278, 1190, 1119, 1044, 989 cm-1; HRMS (APCI): m/z calcd for  C13H15BrCl4O3Na [M + Na]
+ 
476.8806; found: 476.8805. 
(1R*,4R*,5R*)-5-(2-(Bromomethyl)-1,3-dioxolan-2-yl)-1,4-dichloro-7,7-dimethoxybicyclo- 
[2.2.1]heptane-2,3-dione 17. To a stirred solution of 19 (3 g, 6.56 mmol) in acetonitrile (79 mL) 
were added sodium periodate (2.3 g, 10.50 mmol), Ru-LDH (262 mg), NaHCO3 (1.65 g, 19.68 
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mmol) and then water (13.1 mL) at 0 oC. After being stirred for 4 h, 6 mL of isopropanol was 
added stirred for another 1 h, then solvent was evaporated the residue was diluted with EtOAc 
(100 mL), organic phase was separated aqueous phase was extracted with EtOAc (100 mL x 2), 
combined organic phase was washed with Na2S2O3 solution (50 mL x 2), water (100 mL), brine 
(50 mL) dried over Na2SO4 and concentrated under reduced pressure. The resulting crude was 
purified over silica gel column chromatography (15% EtOAc in hexane) to afford 17 (2.52 g, 
92%) as yellow colored solid (needles- crystallized from CH2Cl2: Hexane (1:5)); mp: 96-98 °C; 
Rf = 0.5 (15% EtOAc in hexane). 
1H NMR (400 MHz, CDCl3) δ4.11-4.04 (m, 2H), 4.00-3.93 (m, 
1H), 3.76-3.69 (m, 1H), 3.73 (s, 3H),  3.60-3.54 (m, 1H), 3.55 (s, 3H), 3.35 (dd, J 11.3, 18.5 Hz, 
2H), 2.78-2.68 (m, 1 H), 2.11 (dd, J 4.4, 12.7 Hz, 1 H). 13C NMR (100 MHz, CDCl3) δ 188.3, 
186.5, 108.7, 102.4, 77.1, 74.0, 66.4, 65.1, 52.8, 52.3, 48.3, 33.8, 32.9. IR (neat) 2955, 2918, 
2850, 1772, 1453, 1330, 1294, 1197, 1119, 1053 cm-1; HRMS (ESI): m/z calcd for 
C13H16BrCl2NO6 [M + NH4]
+ 473.9222; found 473.9199. 
(1R*,4R*,6R*)-6-(2-(Bromomethyl)-1,3-dioxolan-2-yl)-1,4-dichloro-7,7-dimethoxy-3-
ethylenebicyclo[2.2.1]heptan-2-one 16. To a stirred suspension of methyltriphenylphosphonium 
bromide (3.07 g, 8.61 mmol) in THF (25 mL) was added potassium tert-butoxide (900 mg, 8.03 
mmol) at 0 °C and then allowed to warm to room temperature and stirred. After being stirred at rt 
for 2 h the resulting ylied was cooled to -78 °C and a solution of 17 (2.4 g, 5.74 mmol) in THF (8 
mL) was added. After being stirred for 30 min (monitored by TLC), 10 mL of water was added 
slowly drop wise. The reaction mixture was diluted with EtOAc (75 mL), organic phase was 
separated, aqueous phase was extracted with EtOAc (75 mL x 3) combined organic phase was 
washed with water (100 mL), brine (50 mL), dried over Na2SO4 and concentrated under reduced 
pressure. The resulting crude was purified over silica gel column chromatography (12% EtOAc 
in hexane) to afford 17 (2.3 g, 97%) as a colorless solid (needles: crystallized from acetonitrile); 
mp: 80-82 °C; Rf = 0.6 (15% EtOAc in hexane). 
1H NMR (400 MHz, CDCl3) δ 6.18 (s, 1H), 
5.67 (s, 1H), 4.15-4.02 (m, 2H), 3.97 (q, J 7.3 Hz, 1H), 3.86-3.78 (m, 1H), 3.69 (s, 3H), 3.50 (s, 
3H), 3.42-3.31 (m, 3H), 2.74 (t, J 12.0 Hz, 1H), 2.01 (dd, J 4.9, 11.7 Hz, 1H). 13C NMR (100 
MHz, CDCl3) δ 188.7, 146.1, 116.0, 108.6, 105.1, 78.0, 69.4, 66.5, 65.6, 52.2, 51.8, 46.3, 39.4, 
34.8. IR (neat) 2982, 2953, 2904, 2844, 1755, 1660, 1450, 1395, 1295, 1208, 1169, 1112, 1058, 
1020 cm-1; HRMS (ESI): m/z calcd for C14H21BrCl2NO5 [M + NH4]
+ 433.9960; found: 433.9951. 
(1R*,4R*,6R*)-6-(2-(Bromomethyl)-1,3-dioxolan-2-yl)-1,4-dichloro-7,7-dimethoxy-3-(3-
oxobutyl)bicyclo[2.2.1]heptan-2-one 20. To a stirred solution of 16 (2 g, 4.8 mmol) in acetone 
(30 mL) was added 2N NaOHaq (2.9 mL, 5.8 mmol) at 0 °C. After being stirred for 2 h, 2 mL of 
10% HCl was added, diluted with EtOAc (70 mL), organic phase was separated, aqueous phase 
was extracted with EtOAc (80 mL x 3) combined organic phase was washed with water (100 
mL), brine (50 mL), dried over Na2SO4 and evaporated under reduced pressure. The resulting 
crude was purified over silica gel column chromatography (20% EtOAc in hexane) to give 20 
(2.23 g, 98%) as a colorless solid (needles: crystallized from acetonitrile); mp: 70-72 °C; Rf = 0.5 
(20% EtOAc in hexane). 
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 NMR data for major isomer.1H NMR (400 MHz, CDCl3) δ4.17-4.09 (m, 1H), 4.08-4.02 (m, 
1H), 3.97 (q, J 7.3 Hz, 1H), 3.84-3.75 (m, 1H), 3.68 (s, 3H), 3.59 (s, 3H), 3.38 (d, J 3.4 Hz, 2H), 
3.29 (dd, J 5.1, 12.0 Hz, 1H), 2.98-2.84 (m, 1H), 2.84-2.72 (m, 2H), 2.50 (dt, J 2.4, 12.5 Hz, 
1H), 2.21 (d, J 5.4 Hz, 1H), 2.18 (s, 3H), 2.12-1.86 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 
207.9, 201.4, 108.6, 104.9, 78.4, 68.4, 66.1, 65.4, 55.4, 51.8, 46.4, 41.4, 34.8, 33.4, 30.1, 18.3;  
NMR data for minor isomer: 1H NMR (400 MHz, CDCl3) δ4.17-4.09 (m, 1H), 4.08-4.02 (m, 
2H), 3.97 (q, J 7.3 Hz, 1H), 3.84-3.75 (m, 1H), 3.66 (s, 3H), 3.57 (s, 3H), 3.38 (d, J 3.4 Hz, 1H), 
3.29 (dd, J 5.1, 12.0 Hz, 1H), 2.98-2.84 (m, 1H), 2.84-2.72 (m, 2H), 2.63-2.59 (m, 1H), 2.22-
2.18 (m, 1H), 2.17 (s, 3H), 2.12-1.86 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 208.1, 201.9, 
108.7, 105.3, 77.8, 69.1, 66.3, 65.6, 56.7, 53.7, 51.8, 45.3, 42.4, 41.0, 34.6, 30.0, 23.4. IR (neat) 
2953, 2906, 2846, 1765, 1713, 1452, 1364, 1203, 1108, 1049, 979 cm-1; HRMS (ESI): m/z calcd 
for C17H24BrCl2O6 [M + H]
+ 475.0113; found: 475.0088. 
Twist-brendane 15. To a stirred solution of 20 (2 g, 4.21 mmol) in THF (42 mL) was added 
NaH (220 mg, 5.48 mmol, 60% in mineral oil) at 0 °C and slowly allowed to warm to room 
temperature and then heated at 60 °C. After being heated for 5 h, reaction mixture was cooled to 
0 °C and added 10 mL of water drop wise, solvent was evaporated. The resulting residue was 
diluted with EtOAc (75 mL), organic phase was separated aqueous phase was extracted with 
EtOAc (80 mL x 3), combined organic phase was washed with water (70 mL), brine (40 mL), 
dried over Na2SO4 and concentrated under reduced pressure. The resulting crude was purified 
over silica gel column chromatography (25% EtOAc in hexane) to give 15 (1.49 g, 90%) as a 
colorless solid (needles: crystallized from acetonitrile); mp: 152-154 °C; Rf = 0.5 (25% EtOAc in 
hexane). 1H NMR (400 MHz, CDCl3) δ 4.02-3.89 (m, 3H), 3.85-3.77 (m, 1H), 3.60 (s, 3H), 3.42 
(s, 3H), 2.80-2.69 (m, 2H), 2.66 (dd, J 5.1, 11.0 Hz, 1H), 2.53 (d, J 7.3 Hz, 1H), 2.49 (d, J 14.2 
Hz, 1H), 2.17 (d, J 11.7 Hz, 1H), 2.14 (s, 3H), 2.08 (dd, J 5.1, 10.8 Hz, 1H), 1.96 (dd, J 4.9, 10.8 
Hz, 1H), 1.81 (dd, J 1, 14.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 208.1, 201.5, 108.1, 104.3, 
74.2, 73.3, 65.3, 64.4, 55.0, 54.6, 51.6, 51.2, 42.4, 38.9, 35.6, 29.9, 24.3. IR (neat) 2984, 2950, 
2848, 1783, 1713, 1441, 1335, 1192, 1141, 1080 cm-1; HRMS (ESI): m/z calcd for C17H23Cl2O6 
[M+H]+ 393.0872; found: 393.0852. 
(1R*,4S*,5R*)-Methyl 2,5-dichloro-3-oxo-4-(3-oxobutyl)spiro[bicyclo[2.2.2]octane-7,2'-
[1,3]dioxolane]-5-carboxylate 21. To a stirred solution of 15 (500 mg, 1.27 mmol) in toluene 
(12 mL) was added pTSA (290 mg, 1.52 mmol) at room temperature and then slowly warm to 80 
°C. After being stirred for 4.5 h, 2 mL of water was added, diluted with EtOAc (50 mL), organic 
phase was separated aqueous phase was extracted with EtOAc (50 mL x 3), combined organic 
phase was washed with NaHCO3 (10 mL), water (50 mL), brine (40 mL), dried over Na2SO4 and 
concentrated under reduced pressure. The resulting crude was purified over silica gel column 
chromatography (30% EtOAc in hexane) to give 25 (424 mg, 88%) as a colorless liquid in 45:55 
(exo:endo) ratio; Rf = 0.5 (25% EtOAc in hexane). NMR data for exo isomer 21b: 
1H NMR (400 
MHz, CDCl3) δ 4.54 (d, J 3.4 Hz, 1H), 4.12-3.91 (m, 4H), 3.85 (s, 3H), 3.14-3.10 (m, 1H), 3.07 
(dd, J 2.7, 7.1 Hz, 1H), 2.72-2.45 (m, 3H), 2.45-2.22 (m, 2H), 2.16 (s, 3H), 2.05-1.87 (m, 1H), 
1.87-1.76 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 206.5, 203.2, 170.8, 106.8, 70.8 (2C), 65.2, 
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58.1, 54.6, 54.5, 51.2, 39.7, 38.1, 38.0, 30.0, 22.5. NMR data for endo isomer 21a: 1H NMR (400 
MHz, CDCl3) δ 4.50 (t, J 2.4 Hz, 1H), 4.12-3.90 (m, 4H), 3.78 (s, 3H), 3.14-3.03 (dd, J 2.4, 7.3 
Hz, 1 H), 2.77-2.62 (m, 3H), 2.61-2.46 (m, 1H), 2.41-2.21 (m, 2H), 2.12 (s, 3H), 2.05-1.87 (m, 
1H), 1.86-1.76 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 207.2, 203.0, 170.4, 106.8, 72.1 (2C), 
64.4, 56.2, 55.3, 53.7, 43.9, 42.3, 38.1, 38.0, 34.8, 29.9, 22.6; IR (neat) 2955, 1745, 1726, 1435, 
1355, 1281, 1245, 1164, 1110 cm-1; HRMS (ESI): m/z calcd for C16H21Cl2O6 [M+H]
+ 379.0715; 
found: 379.0695. 
(1S*,3S*,4R*)-Methyl 5-oxo-4-(3-oxobutyl)spiro[bicyclo[2.2.2]octane-7,2'-[1,3]dioxolane]-3-
carboxylate 14. To a stirred solution of mixture 21 (500 mg, 1.32 mmol) in acetic acid (10 mL) 
was added zinc dust (517 mg, 7.9 mmol) at room temperature. After being stirred for 6.5 h, 
reaction mixture was filtered washed with EtOAc (200 mL) filtrate was washed with NaHCO3 
(60 mL), organic phase separated, aqueous phase was extracted with EtOAc (100 mL x 2), 
combined organic phase was washed with water (100 mL), brine (50 mL), dried over Na2SO4 
and concentrated under reduced pressure. The resulting crude was purified over silica gel column 
chromatography (40% EtOAc in hexane) to give 14 (348 mg, 85%) as a colorless liquid; Rf = 0.4 
(45% EtOAc in hexane). 1H NMR (400 MHz, CDCl3) δ 3.98-3.93 (m, 2H), 3.93-3.86 (m, 2H), 
3.72 (d, J 4.9 Hz, 1H), 3.65 (s, 3H), 2.83 (dd, J 5.6, 11.0 Hz, 1H), 2.59-2.54 (m, 1H), 2.54-2.47 
(m, 1H), 2.45-2.38 (m, 2H), 2.38-2.34 (m, 1H), 2.21-2.14 (m, 2H), 2.13 (s, 3H), 1.92-1.87 (m, 
1H), 1.85-1.74 (m, 1H), 1.54 (ddd, J 5.1, 10.3, 14.9 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 
211.1, 208.0, 174.9, 108.7, 64.6, 64.3, 52.1, 49.2, 45.3, 42.3, 39.8, 38.0, 35.3, 29.8, 26.2, 25.1. IR 
(neat) 2951, 1728, 1665, 1441, 1362, 1339, 1260, 1196, 1170 cm-1; HRMS (ESI): m/z calcd for  
C16H26NO6 [M+NH4]
+ 328.1760; found: 328.1733 
Enone 22. To a stirred solution of 14 (300 mg, 0.967) in MeOH (43 mL) was added NaOH (271 
mg, 6.77mmol) and slowly warmed to reflux temperature. After being refluxed for 12 h, solvent 
was evaporated under reduced pressure, residue was diluted with EtOAc (50 mL), organic phase 
was separated, aqueous phase was extracted with EtOAc (40 mL x 3) combined organic phase 
was washed with dil. HCl (20 mL), water (50 mL x 2), brine (40 mL), dried over Na2SO4 and 
concentrated under reduced pressure. The resulting crude was dissolved in MeOH (15 mL) 
cooled to 0 oC, solution of CH2N2 in ether was added till yellow color persist..A pinch AcOH 
was added to quench excess of diazomethane. Reaction mixture was concentrated under reduced 
pressure, the resulting residue was purified over silica gel column chromatography (25% EtOAc 
in hexane) afforded enone 22 (220 mg, 78%, exo/endo: 4:1) as a colorless liquid. Rf = 0.5 (50% 
EtOAc in hexane). NMR data for exo isomer: 1H NMR (400 MHz, CDCl3) δ 5.96 (s, 1H), 3.98-
3.94 (m, 2H), 3.92 - 3.86 (m, 2H), 3.66 (s, 3H), 2.73-2.65 (m, 2H), 2.41-2.30 (m, 2H), 2.29-2.22 
(m, 1H), 2.21-2.15 (m, 1H), 2.07-1.97 (m, 2H), 1.89-1.79 (m, 2H), 1.74 (ddd, J 5.9, 8.1, 13.9 Hz, 
1H). 13C NMR (100 MHz, CDCl3) δ 197.5, 175.1, 164.7, 125.9, 109.4, 64.3 (2C), 52.0, 47.1, 
46.4, 39.3, 33.6, 33.5, 31.7, 30.1, 26.3. NMR data for endo isomer: 1H NMR (400 MHz, CDCl3) 
δ 5.90 (s, 1H), 3.98-3.94 (m, 2H), 3.92 - 3.86 (m, 2H), 3.71 (s, 3H), 2.73-2.65 (m, 2H), 2.41-2.30 
(m, 2H), 2.29-2.22 (m, 1H), 2.21-2.15 (m, 1H), 2.07-1.97 (m, 2H), 1.89-1.79 (m, 2H), 1.74 (ddd, 
J 5.9, 8.1, 13.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 197.7, 173.9, 165.9, 124.4, 109.2, 64.3 
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(2C), 51.8, 45.3, 42.8, 38.9, 35.3, 34.4, 31.2, 29.5, 26.2. HRMS (ESI): m/z calcd for  C16H20O6Na 
[M + Na]+ 315.1208; found: 315.1210. 
Keto ester 13. To a stirred solution of 22 (190 mg, 0.65 mmol) in acetone (2 mL) was added 6N 
HCl (0.65 mL) at 0 oC and allowed to warm to rt, After being stirred for 2 h (monitored by tlc) 
reaction mixture was diluted with EtOAc (40 mL), organic phase was separated, aqueous phase 
was extracted with EtOAc (40 mL x 3) combined organic phase was washed with water (50 mL), 
brine (30 mL), dried over Na2SO4 and concentrated under reduced pressure. The resulting crude 
was purified over silica gel column chromatography (40% EtOAc in hexane) to afford 13 (134 
mg, 83%, exo:endo: 4:1) as a colorless solid (needles: crystallized from acetonitrile); mp: 110-
112 °C; Rf = 0.4 (50% EtOAc in hexane). NMR data for exo isomer: 
1H NMR (400 MHz, 
CDCl3) δ 6.02 (d, J 2.0 Hz, 1H), 3.72 (s, 3H), 3.09-2.98 (m, 1H), 2.87-2.79 (m, 1H), 2.79-2.70 
(m, 1H), 2.70-2.60 (m, 1H), 2.52-2.45 (m, 1H), 2.44-2.43 (m, 1H), 2.36-2.34 (m, 1H),  2.33-2.05 
(m, 4H), 1.98-1.80 (m, 1H). 13C (100 MHz, CDCl3) δ 210.9, 196.7, 174.3, 161.1, 126.9, 52.4, 
48.4, 46.5, 42.3, 40.8, 33.4, 32.4, 29.8, 27.5. NMR data for endo isomer: 1H NMR (400 MHz, 
CDCl3) δ 5.98 (d, J 2.0 Hz, 1H), 3.75 (m, 3H), 3.09-2.98 (m, 1H), 2.87-2.79 (m, 1H), 2.79-2.70 
(m, 1H), 2.70-2.60 (m, 1H), 2.52-2.34 (m, 3H), 2.33-2.05 (m, 4H), 1.98-1.80 (m, 1H). 13C NMR 
(100 MHz, CDCl3) δ 210.9, 196.7, 174.3, 161.1, 125.7, 50.7, 45.6, 43.7, 42.9, 42.7, 42.4, 40.8, 
27.9, 33.3, 29.3, 27.3. IR (neat): 2952, 1725, 1665, 1450, 1434, 1361, 1336, 1258, 1220, 1196, 
1167, 1029 cm-1; HRMS (ESI): m/z calcd for C14H20NO4 [M+NH4]
+ 266.1392; found: 266.1386. 
Enone 12. To a stirred suspension of methyltriphenylphosphonium bromide (237 mg, 0.66 
mmol) in THF (3 mL) was added potassium tert-butoxide (69 mg, 0.61 mmol) at 0 oC and then 
allowed to warm to room temperature and stirred for 2 h. A solution of 13 (110 mg, 0.44 mmol) 
in THF (1.5 mL) was added at -78 oC and after being stirred for 1 h, 1 mL of water was added 
slowly drop wise. The reaction mixture was diluted with EtOAc (25 mL), organic phase was 
separated aqueous phase was extracted with EtOAc (25 mL x 3) combined organic phase was 
washed with water (30 mL), brine (20 mL), dried over Na2SO4 and concentrated under reduced 
pressure. The resulting crude was purified over silica gel column chromatography (25% EtOAc 
in hexane) to afford 12 (78 mg, 72%, exo/endo:10:1) as a colorless liquid. Rf = 0.5 (30% EtOAc 
in hexane).1H NMR (400 MHz, CDCl3) δ 5.95-5.91 (m, 1H), 4.97-4.87 (m, 1H), 4.72 (s, 1H), 
3.67 (s, 3H), 2.86-2.77 (m, 1H), 2.70 (dd, J 5.9, 10.3 Hz, 1H), 2.60-2.52 (m, 3H), 2.42-2.32 (m, 
2H), 2.25-2.16 (m, 1H), 2.11-1.92 (m, 3H), 1.78 (ddd, J 5.9, 7.6, 13.9 Hz, 1H). 13C NMR (100 
MHz, CDCl3) δ 197.6, 175.1, 166.1, 147.1, 126.0, 107.8, 52.0, 47.4, 40.8, 39.1, 36.2, 35.8, 33.7, 
30.9, 30.1. IR (neat): 2924, 2856, 1730, 1668, 1449, 1434, 1354, 1334, 1232, 1194, 1166, 1044 
cm-1; IR (neat): 2924, 2856, 1730, 1668, 1449, 1434, 1354, 1334, 1232, 1194, 1166, 1044 cm-1; 
HRMS (ESI): m/z calcd for C15H19O3 [M+H]
+ 247.1334; found: 247.1318.  
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